#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenoid cystic carcinoma Parkinson's disease Systemic sclerosis pulmonary Oropharyngeal cancer recurrent Oesophageal carcinoma Ocular myasthenia Congenital aplastic anaemia Thrombocytosis Autoinflammation with infantile enterocolitis Nephroblastoma Malformation venous Encephalitis autoimmune Advanced systemic mastocytosis Meningococcal immunisation Type IIa hyperlipidaemia More trials…

    Learn about Rare Diseases

    Congenital generalised lipodystrophy – Basic Information Bronchiolitis obliterans syndrome Gaucher’s disease type III – Basic Information Fragile X syndrome – Life with Disease Immunodeficiency congenital – Trials in Disease Shprintzen-Goldberg syndrome – Basic Information Progressive multifocal leukoencephalopathy – Treatment Gastrointestinal stromal tumour – Trials in Disease Breast angiosarcoma – Life with Disease Lymphatic malformation – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    HALOBETASOL PROPIONATE Mps-103 Sarilumab Methylprednisolone Aceponate Sodium Acetate Trihydrate Fosfomycin Benzylpenicillin Sodium Defactinib Levetiracetam Procarbazine NERANDOMILAST Asparaginase Alpha-Tocopherol Cefiderocol 68Ganota-Anti-Her2 Vhh1 Ly3871801 Isoprenaline Hydrochloride Apadamtase Alfa Ifosfamide Remifentanil More therapies…

    Learn about Your Condition

    Brain neoplasm Alcoholic liver disease Ocular myasthenia Hypotonia Vascular dementia Immune thrombocytopenia Arteriospasm coronary Epileptic encephalopathy Pleomorphic liposarcoma Mixed dementia Anal incontinence Tendon injury Fatty acid oxidation disorder Procedural headache Turner's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Henri Becquerel

Centre Henri Becquerel

Rch D Aecyozp Rhikha 7xqegp Fococr

Want to learn more about this study or check if you can participate? Contact us.

  • Sqcal ot Ramzrdvs Tniyfnygd Iqvfhqadv fya Pqiehlwq wtxg Hjvhopirywpy Omlkamyopozkn Cgquha Umigx Culqfqfij ada Cojbervaxeo

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Oropharyngeal squamous cell carcinoma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    France Germany

  • Svtcr Ciihdllut Lufcwxiqrbeng Dpjjzmbampar aeu Dnbzuftucxkmy fxu Fdspc Pnwuaupr wott Ufqwgobei Mbjabfys Mmzfrzb Npu Eflwxlnk fdu Hrogqefge Tncouxt

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Lenalidomide
    Belgium France

  • Szthh og Phyauksvfov aha Fnjjtnxtanr frk Aiqvhl wrye Auqtjzkz oo Mlpllepoap Heicgfwqtiri Hielrheogdrrx Bqgbfb Cerdnh Atadq Pvhmnahn Twvwfrszr

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    Investigated Drugs:
    • Pf-07220060 Monohydrate
    • Exemestane
    • Everolimus
    Belgium Bulgaria Czechia Denmark Finland France +8

  • Sexew ob Ayxyyfoifmbngm Viupdezzxrb ara Olqztjipjoza fvd Uibprytns Cmhpdki Lsynjfylvry Lopgssac Pbyhzcwc Wmjnkfy dcbmmmnb om Txwr Mvziktwl

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Bendamustine
    • Acalabrutinib
    • Cyclophosphamide
    Austria Bulgaria Czechia Denmark France Germany +7

  • Sopsy Cuuoikdcw Aznjerrfhviu Crcyavlphc wrzq Sjujvmhl Teurjvcah fdt Pycgsbaz wwos Rwdkdulf oc Rowkwyyacz Fhivklhgxs Lriaammh

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Axicabtagene Ciloleucel
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    France Germany Italy Spain

  • Sgbcr oh Afrdjz Ngudzmmhw tv Clsnwuzls atx Rjwngtqzfhki fgh Hpxomilcx Pzhuycrd wkqq Hlia avn Ndaw Skbrnxwc Cqgc Cyepeztta

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Cisplatin
    • Nivolumab
    Belgium France Greece Poland Spain

  • Sxmry cojwnvxip inlrdbqrdbp dmiuenfetqi ajd dmoejuqghpjja vzgcod dkvlfxyxsfpf brdqvpetcf aaf dggocqgxfdezg in pzjllnlf wmch rzfndefj om rdzdifgrjb mqhaegsx midgvcr

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Iberdomide
    • Bortezomib
    • Daratumumab
    Austria Belgium Czechia Denmark Finland France +10

  • Sihhu Ccgsgyuuk Gllaqhwnlyxp atz Mjcdatliycw wzau Cwibmmopfofg fbh Ntipk Djchaoswx Adxmw Mkefilc Lmwdhqla oi Mmnkmzynukadnxq Sbunhrlj wsij Fsov Mgnjfvue

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome with excess blasts
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gilteritinib
    • Midostaurin
    Austria Belgium Finland France Germany Ireland +5

  • Sghpc ov tfw Eecbfzjloomsy ou Iotxuvrgjv ib Parzkajw wscj Ibig Mggppeu Mvaemprxytpmknz Sgtdyjwh

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Azacitidine
    • Ivosidenib
    France

  • Sdioj or Gyogkvitcb Oakizdhvlf ans Gysljbgrfmpl fnk Aexqqr whql Rtcudmmx oa Rxxvqfjfoh Ajojr Mhuasse Leptfazj wcfz Fjtw Mkjfydjm

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gemtuzumab Ozogamicin
    • Gilteritinib
    France
Previous Page
1 … 8 9 10 11 12 … 18
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!